The efficacy of aconitine A tablets

Aconitine tablets are a common drug for the treatment of rheumatoid arthritis and rheumatoid arthritis. At the same time, it also has a good therapeutic effect on frozen shoulder and lumbar muscle strain. It can also achieve therapeutic effects on sprains. It has a relatively strong sedative effect and has a relatively good anti-inflammatory effect. When using this drug, you should also understand some precautions. It should not be used if you have heart disease, and it should not be used by pregnant women and breastfeeding women.

The efficacy of aconitine A tablets

The main ingredient of aconitine A tablets is aconitine A, whose chemical name is: (1α, 6α, 14α, 16α)-tetrahydro-8,13,14-triol-20-ethyl-1,6,16-trimethoxy-4-methoxymethyl-8-ethanoloxy-14-(4-p-methoxybenzyl ester)-aconitane.

Aconitine tablets have strong analgesic and obvious anti-inflammatory effects. The analgesic effect of Aconitine tablets is central and closely related to the level of 5-hydroxytryptamine in the brain. The analgesic effect is 1.75-2.27 times that of morphine and is non-addictive. At the same time, Aconitine tablets have antipyretic and local anesthetic effects. Pharmacological actions: It has strong analgesic and obvious anti-inflammatory effects. The analgesic effect is central and closely related to the level of 5-hydroxytryptamine in the brain. The analgesic effect is 1.75-2.27 times that of morphine and is non-addictive. At the same time, it has antipyretic and local anesthetic effects. The indication groups are: osteoarthritis, sprains and contusions of limbs, rheumatism and rheumatoid arthritis, bone hyperplasia, periarthritis of shoulder, lumbar muscle strain and lumbar vertebrae disease, cervical vertebrae disease and other painful diseases.

Ingredients

The main ingredient of this product is aconitine A. The chemical name is: (1α, 6α, 14α, 16α)-tetrahydro-8, 13, 14-triol-20-ethyl-1, 6, 16-trimethoxy-4-methoxymethyl-8-ethanoloxy-14-(4-p-methoxybenzyl ester)-aconitane. Chemical structure:

Molecular formula: C35H49O10 Molecular weight: 643.77

Taboo

1. Contraindicated for patients with heart disease. 2. It is forbidden to use in pregnant and lactating women. 3. It is contraindicated for those who are allergic to this product.

Precautions

1. The interval between two doses of medication should not be less than 6 hours. 2. If adverse reactions occur, hypertonic glucose plus vitamin C can be injected intravenously, or atropine can be injected, and the dosage should be reduced or discontinued. If the reaction is extremely severe, it can be treated as aconite poisoning and the drug should be discontinued. 3. It is prohibited to use the drug when its properties change.